GVS has completed a voluntary partial tender offer for its own shares
July 2026 — GVS S.p.A. has completed a voluntary partial public tender offer for 12.3% of its own share capital.
Founded in 1979, GVS develops and manufactures filtration solutions for the healthcare and life sciences, energy and mobility and health and safety sectors. The company focuses on product and process innovation to support its global growth strategy. Headquartered in Bologna, Italy, GVS operates manufacturing facilities in Italy, the UK, Brazil, the USA, China, Malaysia, Mexico, Romania and Puerto Rico, supported by a global network of commercial offices. As a publicly listed company, GVS has a widely dispersed shareholder base.
Our role in the transaction
Oaklins Italy’s parent company, Banca Akros, served as the appointed broker for the collection of shares in GVS’ voluntary partial public tender offer for 12.3% of its own shares.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Conozca másTandem has completed a voluntary public tender offer for the shares of Compagnia dei Caraibi
Tandem S.r.l. has completed a voluntary public tender offer for 25.99% of the shares in Compagnia dei Caraibi S.p.A.
Conozca másICOP has transferred its listing from Euronext Growth Milan to Euronext Milan
ICOP S.p.A. has transferred its listing from Euronext Growth Milan to Euronext Milan.
Conozca más